Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer

Journal of Infection and Chemotherapy

Volumn 15, Issue 5, 2009, Pages 335-339

  Suzuki, Shinsuke ^a   Ishikawa, Kazuo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Head and neck cancer; Metastatic tumor; Palliative treatment; Recurrence; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; NEDAPLATIN;

ADENOSQUAMOUS CARCINOMA; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; HEAD AND NECK CANCER; HUMAN; LEUKOPENIA; MAXILLA CANCER; METASTASIS; MONOTHERAPY; NASOPHARYNX CARCINOMA; NAUSEA; NEUTROPENIA; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; UNDIFFERENTIATED CARCINOMA;

EID: 70350489488     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0712-x     Document Type: Article

References (34)

1. D.M. Parkin F. Bray J. Ferlay P. Pisani 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D 11668491 (Pubitemid 32911406)
2. T.Y. Seiwert E.E. Cohen 2005 State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 1341 1348 10.1038/sj.bjc.6602510 1:CAS:528:DC%2BD2MXjsVSjsb0%3D 15846296 (Pubitemid 40704997)
3. A. Alvi J.T. Johnson 1997 Development of distant metastasis after treatment of advanced-stage head and neck cancer Head Neck 19 500 505 10.1002/(SICI)1097-0347(199709)19:6<500::AID-HED7>3.0.CO;2-2 1:STN:280:DyaK2svisVKntw%3D%3D 9278758
4. J.S. Cooper T.F. Pajak A. Forastiere J. Jacobs K.K. Fu K.K. Ang, et al. 1998 Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck 20 588 594 10.1002/(SICI)1097-0347(199810)20:7<588::AID-HED2>3.0.CO;2-F 1:STN:280:DyaK1cvhsFOjtA%3D%3D 9744457 (Pubitemid 28405799)
5. J.A. Kish A. Weaver J. Jacobs G. Cummings M. Al-Sarraf 1984 Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck Cancer 53 1819 1824 10.1002/1097-0142(19840501)53: 9<1819::AID-CNCR2820530903>3.0.CO;2-R 1:STN:280:DyaL2c7ls1Whsw%3D%3D 6538456
6. R.J. Mercier G.D. Neal D.E. Mattox G.A. Gates T.C. Pomeroy D.D. Von Hoff 1987 Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck Cancer 60 2609 2612 10.1002/1097- 0142(19871201)60:11<2609::AID-CNCR2820601105>3.0.CO;2-E 1:STN:280:DyaL1c%2Flt1Cntg%3D%3D 3676999 (Pubitemid 17161786)
7. T. Shirasaka K. Nakano T. Takechi H. Satake J. Uchida A. Fujioka, et al. 1996 Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602 2606 1:CAS:528:DyaK28XjtlCgurg%3D 8653704
8. T. Shirasaka Y. Shimamato H. Ohshimo M. Yamaguchi T. Kato K. Yonekura, et al. 1996 Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548 557 10.1097/00001813-199607000-00010 1:CAS:528:DyaK28Xltleru78%3D 8862723
9. P. Schoffski 2004 The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors Anticancer Drugs 15 85 106 10.1097/00001813-200402000-00001 15075664
10. Y. Sakata A. Ohtsu N. Horikoshi K. Sugimachi Y. Mitachi T. Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720 10.1016/S0959-8049(98)00211-1 1:CAS:528:DyaK1cXntlShurw%3D 9893658 (Pubitemid 28474225)
11. W. Koizumi M. Kurihara S. Nakano K. Hasegawa 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group Oncology 58 191 197 10.1159/000012099 1:CAS:528:DC%2BD3cXjvVeitr4%3D 10765119
12. A. Ohtsu H. Baba Y. Sakata Y. Mitachi N. Horikoshi K. Sugimachi, et al. 2000 Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group Br J Cancer 83 141 145 10.1054/bjoc.2000.1236 1:CAS:528:DC%2BD3cXltl2mur8%3D 10901361
13. G. Nishimura S. Yanoma H. Mizuno K. Satake T. Taguchi Y. Ikeda, et al. 2000 Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells Cancer Lett 159 1 7 10.1016/S0304-3835(00)00495-X 1:CAS:528:DC%2BD3cXmtF2qtbc%3D 10974399 (Pubitemid 30676207)
14. T. Shien C. Shimizu S. Akashi-Tanaka K. Yonemori T. Kohno T. Hojo, et al. 2008 Clinical efficacy of S-1 in pretreated metastatic breast cancer patients Jpn J Clin Oncol 38 172 175 10.1093/jjco/hyn001 18296424
15. E.D. Tetzlaff J. Faust J.A. Ajani 2006 Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin Gastric Cancer 9 140 143 10.1007/s10120-006-0363-x 16767371 (Pubitemid 43885773)
16. Y. Inuyama A. Kida M. Tsukuda N. Kohno B. Satake 2001 Late phase II study of S-1 in patients with advanced head and neck cancer Gan To Kagaku Ryoho 28 1381 1390 1:STN:280:DC%2BD3Mrntl2isg%3D%3D 11681245
17. H.M. Pinedo G.F. Peters 1988 Fluorouracil: biochemistry and pharmacology J Clin Oncol 6 1653 1664 1:CAS:528:DyaL1MXotA%3D%3D 3049954
18. G.A. Caballero R.K. Ausman E.J. Quebbeman 1985 Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas Cancer Treat Rep 69 13 15 1:STN:280:DyaL2M%2FpvFWnsA%3D%3D 3155649
19. J.J. Lokich J.D. Ahlgren J.J. Gullo J.A. Philips J.G. Fryer 1989 A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study J Clin Oncol 7 425 432 1:STN:280:DyaL1M7nslChsQ%3D%3D 2926468
20. E. Quebbeman R. Ausman R. Hansen T. Becker G. Caballero P. Ritch, et al. 1985 Long-term ambulatory treatment of metastatic colorectal adenocarcinoma by continuous intravenous infusion of 5-fluorouracil J Surg Oncol 30 60 65 10.1002/jso.2930300115 1:STN:280:DyaL28%2FptVGntQ%3D%3D 3935873 (Pubitemid 16249423)
21. M. Tsukuda H. Ogasawara S. Kaneko S. Komiyama M. Horiuchi Y. Inuyama, et al. 1994 A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group Gan To Kagaku Ryoho 21 1169 1177 1:STN:280:DyaK2czgsVantw%3D%3D 8031158
22. H. Kato Y. Ichinose M. Ohta E. Hata N. Tsubota H. Tada, et al. 2004 A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 1713 1721 10.1056/NEJMoa032792 1:CAS:528:DC%2BD2cXjt12mt7c%3D 15102997 (Pubitemid 38501140)
23. S. Noguchi H. Koyama J. Uchino R. Abe S. Miura K. Sugimachi, et al. 2005 Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials J Clin Oncol 23 2172 2184 10.1200/JCO.2005.02.158 1:CAS:528:DC%2BD2MXjsVyiu70%3D 15800310 (Pubitemid 46218709)
24. T. Moynihan R. Hansen T. Anderson E. Quebbeman P. Beatty R. Ausman, et al. 1988 Continuous 5-fluorouracil infusion in advanced gastric carcinoma Am J Clin Oncol 11 461 464 10.1097/00000421-198808000-00010 1:STN:280: DyaL1czgslehtw%3D%3D 3407626
25. S. Morita B. Nakata A. Tsuji Y. Mitachi T. Shirasaka S. Saji, et al. 2007 A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method Jpn J Clin Oncol 37 924 929 10.1093/jjco/hym124 18211983 (Pubitemid 351176483)
26. Z. Morise A. Sugioka J. Fujita S. Hoshimoto T. Kato M. Ikeda 2007 S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas Hepatogastroenterology 54 2315 2318 1:CAS:528:DC%2BD1cXpsl2mtA%3D%3D 18265655
27. W. Koizumi H. Narahara T. Hara A. Takagane T. Akiya M. Takagi, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
28. T. Kodaira N. Fuwa H. Tachibana S. Hidano 2006 Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer Anticancer Res 26 2265 2268 1:CAS:528:DC%2BD28XntV2mt74%3D 16821599
29. A. Watanabe M. Taniguchi T. Yamashita M. Ueda T. Abe T. Kusumi, et al. 2006 Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy Head Neck 28 620 625 10.1002/hed.20379 16475204 (Pubitemid 44025111)
30. J.P. Spano P. Busson D. Atlan J. Bourhis J.P. Pignon C. Esteban, et al. 2003 Nasopharyngeal carcinomas: an update Eur J Cancer 39 2121 2135 10.1016/S0959-8049(03)00367-8 14522369 (Pubitemid 37297736)
31. J.C. Lin J.S. Jan C.Y. Hsu W.M. Liang R.S. Jiang W.Y. Wang 2003 Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 631 637 10.1200/JCO.2003.06.158 12586799 (Pubitemid 46621896)
32. L. Alos M. Castillo A. Nadal M. Caballero C. Mallofre A. Palacin, et al. 2004 Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases Histopathology 44 570 579 10.1111/j.1365-2559.2004.01881.x 1:STN:280:DC%2BD2c3os12itg%3D%3D 15186272 (Pubitemid 38845103)
33. T. Taguchi Y. Inuyama R. Kanamaru K. Hasegawa S. Akazawa H. Niitani, et al. 1997 Phase I study of S-1. S-1 Study Group Gan To Kagaku Ryoho 24 2253 2264 1:STN:280:DyaK1c%2Fotl2rug%3D%3D 9422070
34. M. Tsukuda A. Kida M. Fujii N. Kono T. Yoshihara Y. Hasegawa, et al. 2005 Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer Br J Cancer 93 884 889 10.1038/sj.bjc.6602804 1:CAS:528:DC%2BD2MXhtV2kt7jM 16189518 (Pubitemid 41487013)